141 related articles for article (PubMed ID: 9548227)
1. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
Baulac M; Cavalcanti D; Semah F; Arzimanoglou A; Portal JJ
Seizure; 1998 Feb; 7(1):55-62. PubMed ID: 9548227
[TBL] [Abstract][Full Text] [Related]
2. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
Rejdak K; Lipa A; Kaczyński K; Stelmasiak Z;
Wiad Lek; 2011; 64(2):91-6. PubMed ID: 22026272
[TBL] [Abstract][Full Text] [Related]
5. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
Bruni J
Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
[TBL] [Abstract][Full Text] [Related]
7. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
[TBL] [Abstract][Full Text] [Related]
8. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin in refractory partial epilepsy--a trial in India.
Dixit SN; Jain S; Padma MV; Maheshwari MC
Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of gabapentin therapy in children with refractory partial seizures.
Khurana DS; Riviello J; Helmers S; Holmes G; Anderson J; Mikati MA
J Pediatr; 1996 Jun; 128(6):829-33. PubMed ID: 8648543
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin.
Morris GL
Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
[TBL] [Abstract][Full Text] [Related]
12. A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities.
Bhaumik S; Branford D; Duggirala C; Ismail IA
Seizure; 1997 Apr; 6(2):127-33. PubMed ID: 9153725
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin as adjunctive therapy for partial seizures.
Bruni J
Epilepsia; 1999; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680
[TBL] [Abstract][Full Text] [Related]
14. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt
Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of gabapentin.
Ramsay RE
Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
Handforth A; Treiman DM
Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
[TBL] [Abstract][Full Text] [Related]
18. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients.
Wilson EA; Sills GJ; Forrest G; Brodie MJ
Epilepsy Res; 1998 Jan; 29(2):161-6. PubMed ID: 9477149
[TBL] [Abstract][Full Text] [Related]
19. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
Muscas GC; Chiroli S; Luceri F; Mastio MD; Balestrieri F; Arnetoli G
Seizure; 2000 Jan; 9(1):47-50. PubMed ID: 10667963
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with gabapentin for partial epilepsy.
Ojemann LM; Wilensky AJ; Temkin NR; Chmelir T; Ricker BA; Wallace J
Epilepsy Res; 1992 Nov; 13(2):159-65. PubMed ID: 1464301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
